FDA approves new, non-opioid painkiller Journavx
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Historic FDA approval marks first nonopioid breakthrough since Clinton era
The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
Psychology Today1d
Opioid Crisis: Grading the Progress of National Initiatives
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
FDA approves Vertex's non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive ...
Psychology Today1d
Grading the Progress of National Initiatives on the Opioid Crisis
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
Canada stresses ‘video diplomacy’ to halt Donald Trump’s tariff. What is last-minute effort?
Canada is lobbying the U.S. to show its commitment to border security to avoid tariffs. Officials shared videos of border ...